ORYZON Genomics, announced today that the Company is opening a U.S. operation which will be located at 245 First Street in Cambridge, Massachusetts. After incorporation of its U.S. affiliate, Oryzon Corp, in July 2014, the U.S. arm of Oryzon Genomics is now fully launching its operations in Massachusetts. Oryzon plans to have 15-20% of its total headcount in its U.S. office in the next quarter.
(left to right) Dennis Benzan, Vice Mayor of Cambridge; Angus McQuilken, Massachusetts Life Sciences Center VP for Marketing & Communications; State Representative Jay Livingstone; Lisa Hemmerle, Economic Development Director for the City of Cambridge; Carlos Buesa, President & CEO of Oryzon; Peter Abair, MassBio Director of Economic Development & Global Affairs; and Dr. Russell Greig, Member of Oryzon’s Board of Directors celebrate the opening of the company’s first U.S. office in Cambridge, Massachusetts.
